Evidence map›Paper›PMID 23255555›Full record

ArticleBlood2013

Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.

Cormac Cosgrove, James E Ussher, Andri Rauch, Kathleen Gärtner, Ayako Kurioka, Michael H Hühn, Krista Adelmann, Yu-Hoi Kang, Joannah R Fergusson, Peter Simmonds and 12 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05598346 (Significance and Biological Importance of Mucosal Associated Invariant T Cells in Inflammatory Bowel Disease Patients), which is not on this map. Cited by 197 papers.

0numbers the graph read from it
0cells of the map it votes in
197citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05598346 unknown statusnot on this mapstarted 2023, after this paper: background citation

Significance and Biological Importance of Mucosal Associated Invariant T Cells in Inflammatory Bowel Disease Patients

TypeobservationalSponsorAssiut UniversityRan2023 to 2024Enrolled70ConditionsInflammatory Bowel Diseases
3 · Its place in the literature

Who cites it

197 citing papers in PubMed, 310 citations in OpenAlex.

  1. Trial
  2. Mucosal-associated invariant T cells and Vδ2Clinical and experimental immunology · 2020
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Gastrointestinal MAIT cells in chronic HIV-1 infection.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

137 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 3 countries.

Cormac CosgroveNational Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, UK. pcosgrove@partners.org
James E Ussher
Andri Rauch
Kathleen Gärtner
Ayako Kurioka
Michael H Hühn
Krista Adelmann
Yu-Hoi Kang
Joannah R Fergusson
Peter Simmonds
Philip Goulder
Ted H Hansen
Julie Fox
Huldrych F Günthard
Nina Khanna
Fiona Powrie
Alan Steel
Brian Gazzard
Rodney E Phillips
John Frater
Holm Uhlig
Paul Klenerman
University of Oxford · GBNational Institute for Health Research · GBCentre for Immunity, Infection and Evolution · GBChelsea and Westminster Hospital · GBNational Health Service · GBUniversity Hospital of Basel · CHUniversity Hospital of Bern · CHUniversity Hospital of Zurich · CHWashington University in St. Louis · US

Funding

Optimizing CD8+ T-cell responses against C clade HIV infection in subSaharan AfriR01AI046995 · NIAID · UNIVERSITY OF OXFORD · PI GOULDER, PHILIP J · 2000 to 2014
$6.8M
MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONSR01AI046553 · NIAID · WASHINGTON UNIVERSITY · PI FREMONT, DAVED H., HOFT, DANIEL F. · 2000 to 2014
$4.6M
Medical Research Council G0800176Medical Research Council G108/626NIAID NIH HHS R01 AI046553NIAID NIH HHS R01 AI046995Wellcome Trust 091663Wellcome Trust 091911Wellcome Trust 095688Wellcome Trust 095831Wellcome Trust WT091663MA
6 · The paper itself

Abstract

HIV infection is associated with immune dysfunction, perturbation of immune-cell subsets and opportunistic infections. CD161++ CD8+ T cells are a tissue-infiltrating population that produce IL17A, IL22, IFN, and TNFα, cytokines important in mucosal immunity. In adults they dominantly express the semi-invariant TCR Vα7.2, the canonical feature of mucosal associated invariant T (MAIT) cells and have been recently implicated in host defense against pathogens. We analyzed the frequency and function of CD161++ /MAIT cells in peripheral blood and tissue from patients with early stage or chronic-stage HIV infection. We show that the CD161++ /MAIT cell population is significantly decreased in early HIV infection and fails to recover despite otherwise successful treatment. We provide evidence that CD161++ /MAIT cells are not preferentially infected but may be depleted through diverse mechanisms including accumulation in tissues and activation-induced cell death. This loss may impact mucosal defense and could be important in susceptibility to specific opportunistic infections in HIV.

Indexed as

AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveApoptosisCD8-Positive T-LymphocytesCells, CulturedCohort StudiesEscherichia coliFemaleFlow CytometryHIVHIV InfectionsHumansImmunity, MucosalImmunohistochemistryInterleukin-17Anti-HIV AgentsCCR6 protein, humanInterleukin-17KLRB1 protein, humanNK Cell Lectin-Like Receptor Subfamily BReceptors, CCR5Receptors, CCR6

Identifiers

PMID23255555
PMCPMC3567342
OpenAlexW2143709477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.